Safety of Intravenous Thrombolysis for Wake-up Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2014

Conditions
Ischemic Stroke
Interventions
DRUG

Alteplase (iv t-PA)

0.9 mg/kg (maximum of 90 mg) IV t-PA will be administered with 10% bolus given over 1 minute, the rest given as an infusion over the remaining hour.

Trial Locations (3)

35233

University of Alabama, Birmingham

77030

UT-Houston Health Science Center, Houston

80113

Swedish Medical Center, Englewood

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

The University of Texas Health Science Center, Houston

OTHER